Advancing Interest in Immune Checkpoint Blockade for GI Cancers
June 19th 2018Maria Svensson, MD, Lund University, discusses the growing interest in checkpoint inhibitor blockade treatments for gastrointestinal cancers. In the past, there have been promising results with this treatment in metastatic disease.